跳至主要内容
临床试验/ACTRN12622000234718
ACTRN12622000234718招募中未知

Management of COPD and other Comorbidities in COPD Patients by Dispensing Pharmaceutical Care following the Global Initiative for Chronic Obstructive Lung disease-guidelines (GOLD guidelines 2020) : A Prospective Clinical Trial.

Amjad Khan0 个研究点目标入组 120 人开始时间: 2022年2月9日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
40 Years 至 o limit(—)
性别
All

入选标准

  • Patients only attend the outpatient COPD wards, confirmed diagnosis of COPD by the hospital consultant for at least 1 year with a forced expiratory volume in 1 s (FEV1) of 30–80% of the predicted normal value, patients that hospital consultant agree that the patient is suitable for entering the trial will be included in this study.

排除标准

  • Patients will be excluded from the study if they will have moderate to severe learning difficulties, mobility problems, confusion, disorientation or terminal illness, congestive heart failure or if they are attending a pulmonary rehabilitation programs consulting a pulmonary nurse or clinical pharmacist in the last 6 month will be excluded.

研究者

发起方
Amjad Khan

相似试验